Immunohistochemical investigations on middle ear mucosa remnants in cases with cholesteatoma;Immunhistochemische untersuchungen von mittelohrschleimhautresten im cholesteatom

HNO

Volumn 45, Issue 8, 1997, Pages 630-635

  Sudhoff, H ^a,d   Borkowski, G ^a   Bujia, J ^b   Hildmann, H ^a   Fisseler Eckhoff, A ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUT FÜR PATHOLOGIE   (Germany)

^d St Elisabeth Hospital Bochum   (Germany)

Author keywords

Cholesteatoma; Cytokines; Immunohistochemistry; Middle ear mucosa; Pathogenesis; Transforming growth factors

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; INTERLEUKIN 1; KI 67 ANTIGEN; MYC PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MIDDLE EAR MUCOSA; MUCOSA INFLAMMATION; ONCOGENE C MYC; SQUAMOUS EPITHELIUM; TISSUE DISTRIBUTION;

BIOLOGICAL MARKERS; CELL DIVISION; CHOLESTEATOMA, MIDDLE EAR; CYTOKINES; EAR, MIDDLE; EPIDERMAL GROWTH FACTOR; EPITHELIUM; GROWTH SUBSTANCES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1; KERATINOCYTES; KI-67 ANTIGEN; MUCOUS MEMBRANE; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030869006     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050138     Document Type: Article

References (36)

1. Ahn JM, Huang CC, Abramson M (1990) Localization of interleukin-1 inhuman cholesteatoma. Am J Otolaryngol 11 71-77
2. Broekaert D, Coucke P, Leperque S et al. (1992) Immunhistochemical analysis of the cytokeratin expression in the middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 101: 931-936
3. Bujia J, Schilling V, Holly A, Siammberger M, Kastenbauer E (1993) Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 113: 364-368
4. Bujia J, Holly A, Schilling V, Pitzke P, Schulz P, Kastenbauer E (1993) Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 103: 326-329
5. Bujia J, Holly A, Kim C, Sudhoff H, Ostos P, Kastenbauer E (1996) Epidermal growth factor (EGF-R) in human middle ear cholesteatoma: analysis of protein production and gene expression. Am J Otol 17. 1-4
6. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
7. Coffey RJ, Lipes NJ, Bascom CC (1983) Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 48: 1596-1602
8. Cordell JL, Falini B, Erber WN et al (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229
9. Cowley GP, Smith JA, Gusterson BA (1986) Increased EGF receptors on human squamous carcinoma cell lines. Br J Cancer 531: 223-229
10. De Maria TF, Yamaguchi T, Lim DJ (1988) Quantitative cytologic and histologic changes in the middle ear after injection of non-typable haemophilus influenzae endotoxin. In: Lim DJ, Bluestone LD, Klien JO, Nelson JD (eds) Recent advances in otitis media with effusion. Decker, Toronto, pp 320-323
11. Dmarello CA (1988) Biology of interleukin 1. FASEB J 2. 108-115
12. Esteban F, Ruiz-Cabello F, Concha A (1990) Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer 66: 1493-1498
13. Fernandez-Herrera J, Sanchez-Madrid F, Garcia-Diez A (1989) Differential expression of the 4F2 activation antigen on human foilicular epithelium in hair cycle. J Invest Dermatol 92: 247-250
14. Friedmann I, Arnold W (1993) Patholgy of the ear, Churchill Livingstone, Edinburgh London
15. Fujioka O, Huang CC (1994) Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolarnygol 251 199-204
16. Holly A, Sujia J, Sanchez-Madrid F (1993) Expression von 4F2-Aktivierungs-Antigen im Mittelohrcholesteatom. Laryngorhinootol 72: 324-327
17. Hsu SM, Rainc L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
18. Lowell S, Juhn SK, Giebink GS (1980) Experimental otitis media following middle ear inoculation of nonviable streptococcus pneumoniae. Ann Otol Rhinol Laryngol 89: 479-482
19. Martel C, Lallemandy D, Cremist C (1995) Specific c-myc and max regulation in epithelial cells. Oncogene 10: 2195-2205
20. 125I epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 86: 260-265
21. Nanney LB (1990) Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol 94 624-629
22. Palva T, Taskinen E (1990) Inflammatory cells in chronic middle ear disease. Acta Otolaryngol (Stockh) 109 124-129
23. Patterson J, Eisinger M, Haynes BF (1984) Monoclonal antibody 4F2 reactive with basal layer keratinocytes: Studies in the normal and hyperproliferative state. J Invest Dermatol 83: 210-213
24. Rapollee DA, Mark D, Banda MJ, Werb Z (1988) Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 241: 708-712
25. Ristow HJ (1987) A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin-1 or related protein. Proc Natl Acad Sci USA 84. 1940-1944
26. Ryan AF, Baird A (1993) Growth factors during proliferation of the middle ear mucosa. Acta Otolaryngol (Stockh) 113: 68-74
27. Schilling V, Bujia J, Negri B, Schulz P, Kastenbauer E (1991) Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 12: 249-253
28. Schulz P, Bujia J, Holly A, Kastenbauer E (1993) Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor-alpha. Am J Otolaryngol 14: 82-87
29. Sporn MB, Roberts AB (1992) Peptidegrowth factors and their receptors. Springer, Berlin Heidelberg New York
30. Stammberger M, Bujia J, Schilling V (1995) Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol 16. 527-531
31. Steinbach E (1985) Das Mittelohrcholesteatom - Pathogenese und Therapie. HNO-Praxis Heute 5: 1-9
32. Steinbach E (1995) Pathogenese des Cholesteatoms. HNO 43: 1-2
33. Strernlau A, Helms J, Muller-Hermelink H-K, Hoppe F, Villiers EM de (1995) Nachweis der DNS humaner Papillomviren (HPV) in einem "aggressiv" wachsenden Cholesteatom. HNO 43: 3-5
34. Sudhoff H, Bujia J, Holly A, Kim C, Fisseler-Eckhoff A (1994) Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 2: 217-221
35. Sudhoff H, Bujia J, Fisseler-Eckhoff A, SchulzFlake C, Kastenbauer E, Hildmann H (1995) Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 105: 1227-1231
36. Vandesande F (1983) Peroxidase-antiperoxidase techniques. In. Cuello AC (ed) Immunohistochemistry. Wiley, Chichester, pp 101-119